This topic contains a solution. Click here to go to the answer

Author Question: A patient is admitted to the hospital with hyperkalemia. The patient is prescribed sodium ... (Read 37 times)

justinmsk

  • Hero Member
  • *****
  • Posts: 524
A patient is admitted to the hospital with hyperkalemia. The patient is prescribed sodium polystyrene sulfonate (Kayexalate). How does this medication lower the patient's potassium level?
 
  A) It decreases the absorption of exogenous potassium.
  B) It increases urinary excretion of potassium.
  C) It combines with potassium ions for elimination.
  D) It releases sodium to acidify urine with potassium.

Question 2

A 69-year-old woman has been taking metformin for the treatment of type 2 diabetes for several years. Which of the following changes in the woman's laboratory values may demonstrate a need to discontinue the medication?
 
  A) A decrease in hemoglobin and hematocrit
  B) A decrease in glomerular filtration rate
  C) A decrease in potassium accompanied by an increase in sodium
  D) An increase in white blood cells



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cassie_ragen

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

C
Feedback:
Sodium polystyrene sulfonate (Kayexalate), a cation exchange resin, administered orally, removes potassium from the body in the stool. Kayexalate does not decrease the absorption of potassium. Kayexalate does not increase urinary excretion of potassium. Kayexalate does not release sodium to acidify urine with potassium.

Answer to Question 2

B
Feedback:
It is essential to discontinue metformin if renal impairment occurs. The other listed changes in laboratory values do not necessarily indicate that metformin should be discontinued.




justinmsk

  • Member
  • Posts: 524
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


FergA

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library